Skip to content

Intervention Research on Negative Emotions in Patients Undergoing Craniomaxillofacial Plastic Surgery

Intervention Research on Negative Emotions in Patients Undergoing Craniomaxillofacial Plastic Surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600125024
Enrollment
Unknown
Registered
2026-05-20
Start date
2026-05-25
Completion date
Unknown
Last updated
2026-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Negative Emotions

Interventions

Control group:After the end of the experiment, a 5 ml intravenous bolus of normal saline was administered
Low-dose esketamine group:Esketamine injection at a dose of 0.2 mg/kg is drawn up, diluted with normal saline to 5 ml, and administered as a slow intravenous bolus over 5 minutes by an anesthesiologis
High-dose esketamine group:Esketamine injection at a dose of 0.4 mg/kg is drawn up, diluted with normal saline to 5 ml, and administered as a slow intravenous bolus over 5 minutes by an anesthesiologi

Sponsors

Plastic Surgery Hospital, Chinese Academy of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1) Age >=18 years old, regardless of gender; 2) Patients who plan to undergo elective surgery in the craniomaxillofacial plastic surgery department of our hospital and need hospitalization; 3) American Society of Anesthesiologists grade I-III; 4) Have clear consciousness, normal cognition and communication skills, can understand the content of this study and complete the scale evaluation; 5) Volunteer to participate in this study and sign written informed consent.

Exclusion criteria

Exclusion criteria: 1) Patients with known allergy to esketamine; 2) Patients with uncontrolled hypertension (systolic blood pressure > 180 mmHg or diastolic blood pressure > 110 mmHg) or severe cardiovascular disease (e.g., unstable angina, recent myocardial infarction, severe heart failure); 3) Patients with a history of increased intracranial pressure, cerebral aneurysm, cerebral hemorrhage or traumatic brain injury; 4) Patients with a history of schizophrenia, bipolar disorder or other serious mental illness; 5) Those with a history of drug abuse or long-term alcohol abuse;

Design outcomes

Primary

MeasureTime frame
Postoperative anxiety and depression status;Postoperative Quality of Recovery;

Secondary

MeasureTime frame
Postoperative pain;Sleep score;Hemodynamics;Postoperative Nausea and Vomiting;

Countries

China

Contacts

Public ContactWang Qianyu

Plastic Surgery Hospital, Chinese Academy of Medical Sciences

wqywqywangqianyu@163.com+86 183 1074 7852

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 30, 2026